Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma

Fig. 3

Patients’ overall survival for each treatment group from the time of the first TACE treatment. No significant differences in overall survival rates were observed among groups 1, 2, and 3. However, group 4 showed a significantly inferior overall survival rate compared with the other 3 groups. Abbreviations: TACE, transcatheter arterial chemoembolization; Tx, treatment; SABR, stereotactic ablative radiotherapy

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us